Search Results  for '600062.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

China Resources Double-Crane Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - China Resources Double-Crane Pharmaceutical Co Ltd (600062-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Feb 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for China Resources Double-Crane Pharmaceutical Company Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

24 Jan 2016 Wright Reports 56 $75.00

China Resources Dubl-Crne Phrmctl Co Ltd: Upgraded to Good

31 Dec 2015 Sadif Analytics Prime 3 $10.00

Are China Resources Dubl-Crne Phrmctl Co Ltd Investors in for a Bumpy Ride?

25 Nov 2015 Sadif Analytics Prime 12 $25.00

China Resources Dubl-Crne Phrmctl Co Ltd: Downgraded to Average

29 Oct 2015 Sadif Analytics Prime 3 $10.00

China Resources Dubl-Crne Phrmctl Co Ltd: Upgraded to Good

17 Aug 2015 Sadif Analytics Prime 3 $10.00

China Resources Dubl-Crne Phrmctl Co Ltd: Downgraded to Above Average

23 Dec 2014 Sadif Analytics Prime 3 $10.00

China Resources Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial Analysis Review

China Resources Double-Crane Pharmaceutical Co., Ltd. (600062) - Financial Analysis Review Summary China Resources Doub...

11 Dec 2014 GlobalData 26 $125.00

Will China Resources Dubl-Crne Phrmctl Co Ltd Deliver Long-Term Returns?

02 Dec 2014 Sadif Analytics Prime 12 $25.00